chrisvoncsefalvay/vaers-outcomes huggingface dataset:
might be an allergic reaction; chest is tight; hives; very achy legs; migraine; very red cheeks; high fever; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (very achy legs), MIGRAINE (migraine), URTICARIA (hives), CHEST DISCOMFORT (chest is tight) and ALLERGY TO VACCINE (might be an allergic reaction) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (very achy legs), MIGRAINE (migraine), ERYTHEMA (very red cheeks) and PYREXIA (high fever). On 10-Mar-2021, the patient experienced URTICARIA (hives). On 11-Mar-2021, the patient experienced CHEST DISCOMFORT (chest is tight). On an unknown date, the patient experienced ALLERGY TO VACCINE (might be an allergic reaction). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (very achy legs), MIGRAINE (migraine), URTICARIA (hives), CHEST DISCOMFORT (chest is tight), ALLERGY TO VACCINE (might be an allergic reaction), ERYTHEMA (very red cheeks) and PYREXIA (high fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication included an unspecified anti-anxiety medication.   This case was linked to MOD-2021-219972 (Patient Link).
Joint pain - bilateral knees since 2013. Left hand pain/cramping since 2013 back pain.
pt received her 2nd dose of Covid vaccine by Pfizer and about 5 minutes later, pt said not feel right. She felt dizzy and light headache. pharmacist gave pt water and ice pack on the forehead, 911 was called, they check her vital signs and didn't admit patient to the hospital.
Patient called stating that starting 1 day following vaccine, she experienced arm, neck and shoulder blade pain sustaining to this day.  Patient followed up with doctor and was prescribed a course of steroids but wanted to notify the pharmacy.
Narrative: Patient reported lightheadedness and diaphoresis following administration of their second dose of covid vaccine. Patient was able to be released with no additional intervention.
I recieved moderna on 1/21 /2021 I experienced some muscle pain and arm soreness for a couple days.after 2 days I had zero side effects until, Today 1/29/2021 around 4pm I started itching and saw my arm swell at the injection site.i took an oral antihistamine with no affect,with steroid cream.still no  affect.i went to my local emergency department after seeing that it was not getting better, where they administered medication and did blood work.
Information has been received from a registered nurse regarding an unknown age and gender patient. On 14-DEC-2012 at 07:45, ZOSTAVAX lot # H016765 was exposed to -14 C for an estimated total time out of range of 13.25 hours. On 18-DEC-2012 at 18:30, ZOSTAVAX lot # H016765 was exposed to -14 C for an estimated total time out of range of 12.75 hours. On 22-DEC-2012 at 18:30, ZOSTAVAX lot # H016765 was exposed to -14 C for an estimated total time out of range of 5 hours. On 17-JAN-2013 at 07:45, ZOSTAVAX lot # H016765 was exposed to -14 C for an estimated total time out of range of 14-25 hours. On 28-JAN-2013, the patient was vaccinated with an out of range dose of ZOSTAVAX (dose and route were not provided) (Lot number H016765). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.
8.5 x 7 cm red warm swollen, pruritic area lt upper arm 6 days p/DTP inject;
I developed a "blurry spot" (later noted to be a scrotoma) in my vision of my right eye a few days after my vaccine. No pain was associated, just a small spot of blurred/rainbow vision. I did not initially connect it to the vaccine, and do not know for sure if it is connected, but it seems pertinent. I was first seen by my optometrist who did a retina scan and found a retinal hemorrhage. I subsequently saw my PCP, a neurologist and a retina specialist. After more scans, I was diagnosed with Acute nueromacular retinopathy. My doctor, who is a specialist in this specific disorder, noted there had been some connections to this very rare disorder and Covid-19, as well as vaccines. Not a lot is known about this disease, but I did have other potential risk factors, such as being on birth control. Hard to say what actually caused it. But the close connection to the vaccine in timing is suspicious. I am personally curious if there are other documented cases.
Child began to withdraw, refused to make eye-contact, and began losing words/skills already mastered. His progress in all areas of development slowed and in many cases regressed. Diagnosed autistic 1/21/01.
arm was sore at the vaccination site; I was tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm was sore at the vaccination site) and FATIGUE (I was tired) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-May-2021, the patient experienced VACCINATION SITE PAIN (arm was sore at the vaccination site) and FATIGUE (I was tired). At the time of the report, VACCINATION SITE PAIN (arm was sore at the vaccination site) and FATIGUE (I was tired) outcome was unknown.            No Concomitant medications were provided  No treatment medications were provided   This case was linked to MOD-2021-264170 (Patient Link).
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 26Sep2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 48 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Then day 8 home test came back VERY positive; Unknown results, notes: As of Day 5 was trending better per home test - pink lines faded consistently for two days. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. Pertinent medical history was unknown. Since 19-FEB-2015 improperly stored VARIVAX (Merck) (dose, route of administration, anatomical location and lot number was unknown) were administered to unspecified number of patients. Concomitant medications were unspecified by reporter. No adverse effects were noted. The outcome of the events was unknown. This case is linked to the case # 1502USA010291 via same reporter link. Additional information has been requested.
fever; red eyes like conjunctivitis; rash on her body, rash on both arms; hives from her head to toe; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as Dose 2, Single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unknown date, started 8 days after 2nd dose, the patient experienced fever, red eyes like conjunctivitis, rash on her body, rash on both arms and hives from her head to toe. It was reported that rash lasted several days and fever lasted 1 week. The outcome of all the events was reported as unknown.  No follow-up attempts were possible; information about lot/batch number could not be obtained.
itchy arms/ itching on arms progressively got worse; red dots started forming around the ankles up to the lower thighs which were not raised or itchy; This is a spontaneous report from a contactable other healthcare professional (patient) received via COVID-19 Vaccine Adverse Event Reporting System. A non-pregnant 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6202), via an unspecified route of administration, administered in the left arm on 02Mar2021, at 12:00 (at the age of 27 years old) as dose 1, single for COVID-19 immunisation. Medical history included allergy to penicillin-related antibiotics. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included colecalciferol (VIT D3) and cyanocobalamin (VIT B12).  The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unspecified date in Mar2021, one to two weeks after the first dose, the patient started having itchy arms and she didn't think much of it because it would go away. Around the same time, red dots started forming around the ankles up to the lower thighs which were not raised or itchy. Itching on arms progressively got worse. The patient went to the doctor and the doctor attributed it to the vaccine and checked platelets for possible petechiae on the patient's legs. On an unspecified date in Mar2021, the patient had got her platelets checked for possible petechiae on her legs and the platelets were normal. On 30Mar2021, the patient underwent spit test for COVID-19 and tested negative. Therapeutic measures were taken as a result of the events which included triamcinolone cream. The patient has not recovered from the events.  No follow-up attempts are needed. No further information is expected.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 17Jun2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 65 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hyperlipidaemia" (unspecified if ongoing). Concomitant medication(s) included: PRAVASTATIN oral, start date: 01Jun2021, stop date: 21Jul2022; DOXYCLINE [DOXYCYCLINE] oral, start date: 01Jun2022, stop date: 04Aug2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-1 test positive: Positive, notes: positive antigen test after about a week of being symptoms free; SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical Course: It was reported that patient had not received other medication in 2weeks. Patient received COVID 19 Treatment from 21Jul2022 to 25Jul2022 via oral route. Known allergies: no. Return of symptoms (head congestion, chills, headache) and positive antigen test after about a week of being symptoms free.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on plausible dose -event relationship post vaccination and no other alternate explanation the causal role of BNT162B2 cannot be excluded for the reported vents.
Patient immediately felt dizzy and shaky upon receiving the first injection. About 30-40 minutes after injection the patient started experiencing chest tightness, severe chest pain, a thunder clap headache and extreme fatigue. Patient also experienced whole body muscle weakness, it was extremely difficult to move or talk. After sleeping for several hours the patient was still experiencing severe chest pain and chest tightness, experiencing pain while breathing and was taken to the Emergency Room for evaluation. At the ER an EKG was done, it was abnormal due to sinus tachycardia. A chest x-ray was clean and blood work was normal. Further testing was done by the patient's Rheumatologist/Allergist/Internist, blood work taken on July 1 included: C-reactive protein, SED levels, CBC, folate, tryptase, SARS COV 2 AN (IGG) Spike, carnitine, and EBV antibody panel. Covid antibody level was 11.78 U (Quest). C-reactive protein and SED rate were normal, EBV panel showed a continued EBV reactivation EBV (VCA) IGG was 398H and EBV (EBNA) IGG was 461H (original EBV reactivation occurred with covid infection in March 2020). Platelet count was 406H, spike in white blood cell count (still in normal range but high end of the scale).
Sinus headache; Can feel the sinuses draining; This is a spontaneous report from a contactable consumer. A 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date not reported), via an unspecified route of administration on 22Jan2021 at a single dose for COVID-19 immunization. Medical history included sinus issues from the past couple of days from an unknown date. Concomitant medications were not reported. It was reported that the patient woke up with a sinus headache, but as the day went on, it's gotten worse and she can feel the sinuses draining. She reported she got the 1st dose of the COVID-19 vaccine at the morning of the report. Outcome of the events was unknown.   Information on the batch/lot number has been requested.
Immediately after vax the pt experienced injection site reaction, the pts right thigh became swollen, hard and painful. Subsequently the pt recovered from all symptoms. No further information is available.
Pt went into A-Fibrillation. EMT's could not regulate, therefore, ambulance took pt to ER.
Patient received 1.8mL of the vaccine equaling a total of 6 doses when patient should have received 0.3mL equaling one dose.
ANGINA, UNSPECIFIED 11/18/2022  &   1/18/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Spoke w/ patient. She received Fluzone HD and Prevnar20 on the same arm on 9/19. She wanted them in the same arm because she didn't want both arms to be sore. She says she began having soreness later that day and it progressed to a stiff neck (she's having trouble moving the neck). It's begun to get better, but she wasn't sure if it was related to the vaccination. We discussed that going forward, we should avoid more than 1 vaccine at a time and possibly consider Flublok or regular dose Fluzone instead of Fluzone HD. She said she just wanted to report it, is not seeking any compensation or further care.
Blood clot on leg; lump on leg; Very painful lump; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of THROMBOSIS (Blood clot on leg) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (Blood clot on leg) (seriousness criterion medically significant), LIMB MASS (lump on leg) and PAIN IN EXTREMITY (Very painful lump). The patient was treated with APIXABAN (ELIQUIS) at an unspecified dose and frequency. At the time of the report, THROMBOSIS (Blood clot on leg), LIMB MASS (lump on leg) and PAIN IN EXTREMITY (Very painful lump) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: abnormal (abnormal) a clot in her leg.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Patient was currently on a blood thinner medication.  This case concerns a 75-year-old female with a serious unexpected event of thrombosis, and nonserious limb mass and pain in extremity. Event onset with unknown latency after mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow-up information received on 01-JUL-2021: Email address of primary reporter added, additional reporter added, vaccination facility updated. On 06-Jul-2021: Significant follow-up received - Case upgraded to serious; Sender's Comments: This case concerns a 75-year-old female with a serious unexpected event of thrombosis, and nonserious limb mass and pain in extremity. Event onset with unknown latency after mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient states she received incorrect vaccination administration. She has complaints of arm pain and inability to move her arm to a certain extent. She received vaccination over 2 months ago and seem to still have mild pain and issues with arm movement.
Burning when urinating, chills, diarrhea, pain in body when to the hospital 13 days after. She is hospitalized with Hx. of acute colitis.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2012, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the long-term prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 05-AUG-2016, the patient was treated by a physician for the onset of a vesicular rash, which was diagnosed as herpes zoster or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
fever, chills, fainting spell, severe body aches, redness of arm that injection was given-from shoulder to elbow, severe arm pain-limited movement in arm. Still having low grade fever and arm pain and redness.
Flu shot - she has had before.  Given in left arm and felt fine.  Prevnar 20 - then given in right arm.  Then described tongue tingling/sense of swelling but not visibly swollen. Benedryl given.  Minutes later began coughing.  Epinephrine given, albuterol nebs.  911 called and transported to ER.
Pt developed swelling, pain and redness over entire left anterior thigh. He had no generalized rash or systemic symptoms.
Slept all next day; exhausted; sore across her shoulders; "hard as nails, "Felt out of whack"; dizzy; sore arm; off balance; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), BALANCE DISORDER (off balance), FEELING ABNORMAL ("hard as nails, "Felt out of whack"), DIZZINESS (dizzy) and HYPERSOMNIA (Slept all next day) in a 120-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concurrent medical conditions included Allergy (Allergies include codeine).    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and BALANCE DISORDER (off balance). On 28-Mar-2021, the patient experienced FEELING ABNORMAL ("hard as nails, "Felt out of whack"), DIZZINESS (dizzy), FATIGUE (exhausted) and ARTHRALGIA (sore across her shoulders). On 29-Mar-2021, the patient experienced HYPERSOMNIA (Slept all next day). At the time of the report, PAIN IN EXTREMITY (sore arm), BALANCE DISORDER (off balance), FEELING ABNORMAL ("hard as nails, "Felt out of whack"), DIZZINESS (dizzy), HYPERSOMNIA (Slept all next day), FATIGUE (exhausted) and ARTHRALGIA (sore across her shoulders) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Jan-2021, COVID-19: (Positive) Tested positive for Covid.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. The treatment information was unknown.
On 4/9 developed body aches, cough, headache, and nasal congestion.  Tested positive for COVID.
Patient did not have his vaccine card.  First dose COVID vaccine administration  was not verified.  Patient realized that he received Pfizer after nurse administered Moderna.  Dr. notified.  Advised 15 minutes observation and get a set of VS at the 15 minute mark.  If stable may go home.  Pt was stable, no reactions noted.
severely painful paresthesias in the upper and lower extremities, head and trunk, neck and back pain, headache, and feelings of weakness that began 2 weeks after first vaccination, significantly worsened after second dose. EMG/NCS essentially normal. Skin biopsies consistent with small fiber neuropathy.  She has a painful small fiber neuropathy, most likely a post-vaccine complication
8 days post injection I have a large red circle that is hot to the touch. The spot is itchy but not painful.
A report was received from a healthcare professional on 30 October 2003 concerning approximately 10 vaccinees under 4 years of age of unknown demographics who inadvertently received 0.25ml of Fluvirin on an unspecified date. On an unspecified date approximately 10 vaccinees under 4 years of age inadvertently received 0.25ml of Fluvirin.  No adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.